Apimeds Pharmaceuticals US, Inc (APUS)
- Previous Close
2.2000 - Open
2.2400 - Bid 1.8800 x 1300
- Ask --
- Day's Range
1.7350 - 2.2800 - 52 Week Range
1.7200 - 4.0000 - Volume
378,042 - Avg. Volume
1,030,994 - Market Cap (intraday)
22.975M - Beta (5Y Monthly) --
- PE Ratio (TTM)
-- - EPS (TTM)
-0.1200 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Apimeds Pharmaceuticals US, Inc. operates as a clinical stage biopharmaceutical company in the United States. It researches, develops, manufactures, commercializes, and sells Apitox, an active pharmaceutical ingredient for the treatment of inflammation and pain management symptoms associated with osteoarthritis and multiple sclerosis. The company was incorporated in 2020 and is based in Hopewell, New Jersey.
www.apimedsus.com2
Full Time Employees
December 31
Fiscal Year Ends
Sector
Recent News: APUS
View MorePerformance Overview: APUS
Trailing total returns as of 5/12/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: APUS
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: APUS
View MoreValuation Measures
Market Cap
22.98M
Enterprise Value
23.57M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
--
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-366.30%
Return on Equity (ttm)
--
Revenue (ttm)
--
Net Income Avi to Common (ttm)
-1.39M
Diluted EPS (ttm)
-0.1200
Balance Sheet and Cash Flow
Total Cash (mrq)
3.46k
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
-294k